Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2026-01-05 @ 3:16 AM
Study NCT ID:
NCT00267059
Status:
COMPLETED
Last Update Posted:
2012-08-07
First Post:
2005-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2009-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-19
First Submit QC Date:
None
Study First Post Date:
2005-12-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-09-24
Results First Submit QC Date:
None
Results First Post Date:
2011-04-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-01
Last Update Post Date:
2012-08-07
Last Update Post Date Type:
ESTIMATED